AVC-BOOSTER
DEAD

Serial Number

79415723

Owner

Avidicure IP B.V.

Filing Date

Dec 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AVC-BOOSTER Trademark

Serial Number: 79415723

AVC-BOOSTER is a trademark filed by Avidicure IP B.V. on December 17, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

Avidicure IP B.V. (2 trademarks)

Gooimeer 2 35

Entity Type: 16

Trademark Details

Filing Date

December 17, 2024

Registration Date

Not Registered

Goods & Services

Medical services; medical and pharmaceutical advisory and consultancy services; medical care services.

Educational services, namely, arranging and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug research, and/or drug and pharmaceutical development; training services, namely, providing training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug research, and/or drug and pharmaceutical development

Legal services relating to the exploitation of patents; management and licensing of patents; licensing of intellectual property.

Medical and scientific research services; industrial research services in the field of treatment of cancer, inflammatory diseases, auto immune diseases and/or infectious diseases; pharmaceutical and biopharmaceutical research and development services; development, research, laboratory analysis and testing of pharmaceutical and biopharmaceutical drugs and for semi-finished chemicals and chemical products for use in pharmaceuticals; development of test systems in the nature of cell culture models, animal models and companion diagnostics for pharmaceutical and biopharmaceutical products; chemical analysis; computer system analysis and programming, namely, the development of prototypes and collection and processing of medical data for scientific research, development of databases in the medical, pharmaceutical and biopharmaceutical fields

Chemical products for use in industry, science, and photography, namely, monoclonal antibodies and recombinant proteins used in scientific in-silico, in­vitro, in-vivo, and/or clinical research and development relating to immuno­oncology

Pharmaceutical substances and preparations for human use, namely for treatment for cancer, inflammatory diseases, auto immune diseases and/or infectious diseases; biopharmaceutical substances and preparations for human use, namely for treatment for cancer, inflammatory diseases, auto immune diseases and/or infectious diseases

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 17, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 17, 2026 ABN2
NEW REPRESENTATIVE AT IB RECEIVED
Sep 5, 2025 NREP
REFUSAL PROCESSED BY IB
Aug 23, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 2, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 2, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 12, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 11, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 14, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 14, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 30, 2025 REPR